EA
WST icon

Emerald Acquisition’s West Pharmaceutical WST Stock Holding History

Emerald Acquisition’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$213K Sell
2,854
-4,001
-58% -$318K ﹤0.01% 2673
2016
Q2 		$520K Buy
+6,855
New +$499K ﹤0.01% 2456

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's WST Position: Q3 2016 in Review

Emerald Acquisition reduced its West Pharmaceutical (WST) stake by 58% in Q3 2016, selling an estimated $318K and leaving 2,854 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #2673.

Emerald Acquisition first reported a position in WST in Q2 2016 and has held it in 2 quarters since. The position peaked at $520K in Q2 2016. 278 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • Emerald Acquisition held 2,854 shares of West Pharmaceutical worth $213K as of Q3 2016.
  • Emerald Acquisition sold 4,001 West Pharmaceutical shares in Q3 2016, an estimated $318K.
  • West Pharmaceutical made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2673 holding.
  • Emerald Acquisition first reported a position in West Pharmaceutical in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's West Pharmaceutical position peaked at $520K in Q2 2016.
  • 278 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.